2019
DOI: 10.1016/j.parkreldis.2019.05.014
|View full text |Cite
|
Sign up to set email alerts
|

Regional neuropathology distribution and verbal fluency impairments in Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 32 publications
0
7
0
Order By: Relevance
“…These results may be explained mechanistically by RBD in PD being associated with greater impairment in frontal and temporal brain circuitry, specifically with connections implicated in verbal executive functions that are unrelated to PD-specific pathology [51,52]. As neurodegeneration progresses, RBD may amplify verbal impairments found in PD, particularly those that involve switching, that already exist.…”
Section: Discussionmentioning
confidence: 99%
“…These results may be explained mechanistically by RBD in PD being associated with greater impairment in frontal and temporal brain circuitry, specifically with connections implicated in verbal executive functions that are unrelated to PD-specific pathology [51,52]. As neurodegeneration progresses, RBD may amplify verbal impairments found in PD, particularly those that involve switching, that already exist.…”
Section: Discussionmentioning
confidence: 99%
“…Secondly, this could suggest that co-occurring AD pathology accounts for semantic fluency impairment in PD-MCI. However, recent work by El-Nazer et al (2019) concluded that PD and PD/AD mixed pathologies do not differ clinically and that cognitive deficits are associated with both LB and AD pathological burden. Specifically, greater Lewy body density was found in limbic and cortical structures in PD patients with poor verbal fluency, but higher AD pathology was on trend in many of the same areas.…”
Section: Pd-mcimentioning
confidence: 99%
“…Attention, visuospatial, and executive dysfunction are cognitive hallmarks of DLB, [ 38 ] and motor parkinsonism is a core clinical feature of DLB [ 3 ]. As limbic LB pathologies is related to visuospatial and executive dysfunction in patients with DLB [ 39 ] and PD, [ 40 ] our results suggest that relative MTL hypermetabolism could be a disease monitoring biomarker for DLB, reflecting the severity of LB pathologies. Although previous studies have shown that limbic hypermetabolism correlates with dopaminergic depletion in patients with DLB [ 41 , 42 ] and RBD, [ 31 ] we could not evaluate the relationship between relative MTL hypermetabolism, dopamine transporter uptake, cognitive dysfunction, and motor parkinsonism because some of our patients with AD did not undergo FP-CIT-PET.…”
Section: Discussionmentioning
confidence: 85%